Testing The Addition Of An Anti-Cancer Drug, Zen003694, To The Usual Chemotherapy Treatment (Capecitabine) For Metastatic Or Unresectable Cancers
Posted Date: May 17, 2024
- Investigator: Davendra Sohal
- Specialties:
- Type of Study: Drug
This phase I trial tests the safety, side effects, and best dose of ZEN003694 in combination with the usual treatment with capecitabine in treating patients with cancer that has spread from where it first started (primary site) to other places in the body (metastatic) or cannot be removed by surgery (unresectable) and that it has progressed on previous standard treatment.
Criteria:
Null
Keywords:
Metastatic, Unresectable
For More Information:
Kayla Webb
NULL
cancer@uchealth.com